Company intelligence / Profile preview

invivodata

Pittsburgh, PA, USA

Ownership: Private
Development stage: Other

Overview

invivodata’s electronic Patient Reported Outcomes (ePRO) solutions and consulting services have supported over 300 clinical programs, delivering validated data capture technology and regulatory-proven patient outcome strategies for biopharma sponsors and CROs. Company reported three consecutive years of growth through 2011 before its acquisition in 2012.

Therapeutic areas: Other
Modalities: DeviceNon-pharmacological therapy
Industry: Drug Discovery Services

Partnerships

CROsBiopharma sponsors

Beyond the preview

Go deeper on invivodata.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on invivodata.

Explore the full profile